Adenomatous Polyp Prevention on VIOXX

Acronym

Definition

APPROVe

References in periodicals archive	?		Acronyms browser	?		Full browser	?
The Adenomatous Polyp Prevention on Vioxx (APPROVe) (6) trial was a placebo-controlled trial, whose aim was to prove efficacy of rofecoxib in the prevention of recurrent polyps. Serious gastrointestinal and cardiovascular events associated with ... by Sinxadi, Phumla; Blockman, Marc / CME: Your SA Journal of CPD Merck withdrew Vioxx from the market in 2004 after a three-year study (called Adenomatous Polyp Prevention on Vioxx, or APPROVe) of about 2,600 people found that Vioxx users had a greater risk of thrombotic cardiovascular events such as heart attack and stroke than those taking a placebo, beginning after 18 months of treatment. Vioxx studies question timing of heart attack risk by Burtka, Allison Torres / Trial He referred to blood pressure increases and a signal for heart failure "clearly" outside those of other drugs in the class demonstrated in the Adenomatous Polyp Prevention on Vioxx trial, at a daily dose of 25 mg--effects not seen at lower doses of celecoxib. FDA now reviewing panel's nod to COX-2s: celecoxib garnered nearly ... by Mechcatie, Elizabeth / Clinical Psychiatry News	ADEHT ADEI ADEIC ADEIE ADEIR ADEIS ADEJUC ADEKS ADEKUS ADEL ADELA ADELF ADELIA ADELMA ADELT ADEM ADEMA ADEMARG ADEMAS ADEME ADEMI ADEMM AdeMU ADEN ADENC Adenomatous Polyp Prevention on VIOXX AdeNOS ADENYA ADEO ADEOS ADEP ADEPA ADEPAC ADEPH ADEPM ADEPP ADEPREP ADEPS ADEPT ADEPTT ADEQ ADEQUAT ADER ADERA ADERC ADERE ADERTF ADES ADESCO ADESFAM ADESKI	adenomalacia adenomas adenomas adenomas adenomata adenomata adenomata adenomatoid adenomatoid adenomatoid Adenomatoid odontogenic tumor Adenomatoid odontogenic tumor Adenomatoid odontogenic tumor adenomatoid tumor adenomatoid tumor adenomatosis adenomatosis adenomatosis adenomatosis oris adenomatous adenomatous adenomatous adenomatous goiter adenomatous goiter adenomatous goiter Adenomatous Hyperplastic Nodule adenomatous intestinal hyperplasia adenomatous polyp adenomatous polyp adenomatous polyp Adenomatous Polyp Prevention on VIOXX Adenomatous polyposis coli Adenomatous polyposis coli Adenomatous polyposis coli Adenomatous polyposis coli Adenomatous polyposis coli protein Adenomatous Polyposis of the Colon Adenomatous Polyposis of the Colon adenomatous polyps Adenome Adenome Adenome adenomegaly adenomegaly adenomere adenomere adenomyoepithelioma adenomyofibroma adenomyofibromas adenomyofibromata adenomyoma adenomyoma adenomyomas adenomyomas adenomyomata adenomyomata adenomyomatosis adenomyometritis adenomyosarcoma adenomyosarcoma adenomyosarcomas

References in periodicals archive

Acronyms browser

Full browser

The Adenomatous Polyp Prevention on Vioxx (APPROVe) (6) trial was a placebo-controlled trial, whose aim was to prove efficacy of rofecoxib in the prevention of recurrent polyps.

Serious gastrointestinal and cardiovascular events associated with ... by Sinxadi, Phumla; Blockman, Marc / CME: Your SA Journal of CPD

Merck withdrew Vioxx from the market in 2004 after a three-year study (called Adenomatous Polyp Prevention on Vioxx, or APPROVe) of about 2,600 people found that Vioxx users had a greater risk of thrombotic cardiovascular events such as heart attack and stroke than those taking a placebo, beginning after 18 months of treatment.

Vioxx studies question timing of heart attack risk by Burtka, Allison Torres / Trial

He referred to blood pressure increases and a signal for heart failure "clearly" outside those of other drugs in the class demonstrated in the Adenomatous Polyp Prevention on Vioxx trial, at a daily dose of 25 mg--effects not seen at lower doses of celecoxib.

FDA now reviewing panel's nod to COX-2s: celecoxib garnered nearly ... by Mechcatie, Elizabeth / Clinical Psychiatry News